Chih-Hung Lo

Title: Chih-Hung Lo: Innovator in Cardiovascular Treatments

Introduction

Chih-Hung Lo is a notable inventor based in Rockville, MD, who has made significant contributions to the field of medicine through his innovative patents. With a total of three patents to his name, he has focused on developing treatments for conditions such as hypertriglyceridemia and heart failure. His work exemplifies the intersection of scientific research and practical application in healthcare.

Latest Patents

Chih-Hung Lo's latest patents include the development of apolipoprotein C-II (apoC-II) mimetic peptides. This innovation provides methods for treating hypertriglyceridemia in patients by administering an effective amount of these peptides. Another significant patent addresses the treatment of existing left ventricular heart failure. This disclosure outlines methods for treating diuretic resistance by administering an IL-6 antagonist to patients who require diuresis, particularly those with elevated levels of IL-6.

Career Highlights

Throughout his career, Chih-Hung Lo has worked with prominent organizations such as Novo Nordisk A/S and the National Institutes of Health, a component of the US Department of Health & Human Services. His experience in these institutions has allowed him to contribute to groundbreaking research and development in the medical field.

Collaborations

Chih-Hung Lo has collaborated with esteemed colleagues, including Madhav N Devalaraja and Alan Thomas Remaley. These partnerships have further enhanced his research and innovation efforts.

Conclusion

Chih-Hung Lo's contributions to medical science through his patents and collaborations highlight his role as an influential inventor in the field of cardiovascular treatments. His work continues to pave the way for advancements in healthcare solutions.